Blood flow restriction training for Parkinson's (NCT06508801)
Reduce falls by improving balance
- Trial ID
- NCT06508801
- Official Title
- Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
- Goal
- Reduce falls by improving balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson's Disease and Parkinsonism
- Interventions
- Blood flow restriction training, Instability Resistance Training
Summary For Families
The goal is to improve balance and lower fall risk in people with Parkinson's by strengthening the muscles and retraining balance reactions. The approach pairs blood flow restriction training, where a cuff around the upper leg partially limits blood flow during low-load exercises to boost metabolic stress and muscle gains without heavy weights, with instability resistance training that challenges balance on unstable surfaces to improve reactive control. This is an exercise technique to add to, not replace, your usual Parkinson's treatments. The trial is looking for adults 40 to 85 in Hoehn and Yahr stages 2 to 4 with a Mini‑Mental State Exam score of 23 or higher, who do not have serious heart or vascular problems, uncontrolled high blood pressure, recent lower-limb surgery, history of blood clots, very high BMI, or pregnancy.
Locations
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Blood flow restriction training. The goal is to improve balance and lower fall risk in people with Parkinson's by strengthening the muscles and retraining balance reactions. The approach pairs blood flow restriction training, where a cuff around the upper leg partially limits blood flow during low-load exercises to boost metabolic stress and muscle gains without heavy weights, with instability resistance training that challenges balance on unstable surfaces to improve reactive control. This is an exercise technique to add to, not replace, your usual Parkinson's treatments. The trial is looking for adults 40 to 85 in Hoehn and Yahr stages 2 to 4 with a Mini‑Mental State Exam score of 23 or higher, who do not have serious heart or vascular problems, uncontrolled high blood pressure, recent lower-limb surgery, history of blood clots, very high BMI, or pregnancy.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- 2 sessions per week over 6 weeks